Skip to content

Designer Drugs on the Internet: A Phenomenon Out-of-Control? The Emergence of Hallucinogenic Drug Bromo-Dragonfly

Ornella Corazza, Fabrizio Schifano, Magı́ Farré, Paolo Deluca, Zoe Davey, Colin Drummond, Marta Torrens, Zsolt Demetrovics, Lucia di Furia, Liv Flesland, Barbara Mervó, Jacek Moskalewicz, Agnieszka Pisarska, Harry L. Shapiro, Holger Siemann, Arvid Skutle, Cinzia Pezzolesi, Peer van der Kreeft, Norbert Scherbaum

Current reviews in clinical and experimental pharmacology May 1, 2011 DOI: 10.2174/157488411796151129 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Review Peer reviewed
Keywords Phenethylamines Hallucinogen The internet Psychoactive substance Internet privacy Designer drug Dragonfly Toxicology Pharmacology World wide web Ecology
Citations 98
Key findings Online availability of information on Bromo-Dragonfly poses a public health challenge, requiring better international collaboration.

Abstract

Based on the material available in both the scientific literature and on the web, the present paper provides an updated pharmacological, chemical, toxicological and behavioural overview of Bromo-Dragonfly (1-(8-bromobenzo[1,2-b;4,5-b']difuran-4-yl)-2-aminopropane; 'B-fly'). B-Fly is a powerful, long lasting, LSD-like, hallucinogenic drug, which has been associated with a number of acute intoxications and fatalities in a number of countries. A critical discussion of the potential of misuse of B-fly but also of the methodological limitations, which are intrinsically associated with the analysis of online, non-peer reviewed, material, is presented. It is concluded that the availability of online information on novel psychoactive drugs, such as B-fly, may constitute a public health challenge. Better international collaboration levels may be needed to tackle this novel and fast growing phenomenon.

Citations in the library

Cited by 18

and 13 more in the library

Cites 10

and 5 more in the library

Explore topics